Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Evaluating the Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Supportive care, Treatment
Active
18 to 75
NIMH
R01 MH071580
DATR A3-NSS, NCT00352885
2.
Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving Treatment
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Supportive care
Active
19 and over
NIMH
R01 MH079420
DAHBR 96-BHC, NCT00536172
Last Modified:
12/8/2006
 
First Published:
10/6/2006
3.
Randomized Study of Escitalopram Oxalate in Treating a Major Depressive Disorder in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Active
35 to 85
NCI
MGH-2006-P-000299
NCT00387348
Last Modified:
11/19/2008
 
First Published:
4/23/2008
4.
Study of the Pharmacokinetics of Tamoxifen Citrate in Women With or At High Risk For Developing Breast Cancer Who Are Receiving Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor Therapy Comprising Venlafaxine, Citalopram Hydrobromide, Escitalopram Oxalate, Gabapentin, or Sertraline Hydrochloride for the Treatment of Hot Flashes, Depression, or Any Other Medically Indicated Condition
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Biomarker/Laboratory analysis, Treatment
Active
18 and over
NCI
MAYO-MC0738
MC0738, NCT00667121
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute